期刊文献+

CD36在冠状动脉成形术后再狭窄中的临床意义

Effects of CD36 on in-stent restenosis in coronary artery
下载PDF
导出
摘要 目的探讨CD36与冠脉支架介入治疗术后冠状动脉再狭窄的关系。方法选择308例行冠脉支架置入术的冠心病患者,分别于术前,术后1个月,6个月,采用ELISA法检测患者血清CD36、C反应蛋白(CRP)、VCAM-1的表达水平。按照冠状动脉狭窄评分(CSA)标准,将29例支架术后再狭窄患者分为A、B、C3组。结果与术前比较,冠心病患者术后1个月,6个月的CD36、CRP、VCAM-1水平均有显著降低;与术后未狭窄组比较,术后再狭窄组上述指标则明显增高;CD36、CRP、VCAM-1水平随CSA评分的升高而升高;CD36、CRP、VCAM-1与术后再狭窄呈正相关性。结论 CD36、CRP、VCAM-1与支架术后冠状动脉再狭窄形成有一定的相关性,对其表达水平的检测有助于冠脉支架术后临床疗效的评价。 Objective To study the effect of CD36 on coronary artery restenosis after coronary artery stent interpolation(CASI).Methods Three hundred and eight patients with coronary artery disease received CASI.Hematology levels of CD36,CRP,VCAM-1of all 308 patients were measured by enzyme-linked immunosorbent assay(ELISA),respectively,before,1 and 6 months after CASI.According to CSA criteria,29 cases of coronary artery restenosis after CASI were classified into group A,group B and group C.Results Compared with the values before the interventional therapy,hematology levels of CD36,CRP,VCAM-1 among the selected patients,without exception,decreased significantly 1 month and 6 months after CASI.In the cases o f post-CASI coronary artery restenosis,the previously mentioned corresponding items increased evidently,and the values were positively correlated with CSA grade and severity of CAD.Conclusion CD36,CRP,VCAM-1 are related to coronary artery restenosis after CASI.The measurement of hematology levels of it is some value in the prognosis of coronary artery restenosis.
出处 《中国实用医药》 2011年第35期12-14,共3页 China Practical Medicine
关键词 CD36 冠状动脉狭窄 VCAM-1 C反应蛋白 CD36 Coronary stenosis VCAM-1 CRP
  • 相关文献

参考文献17

  • 1Co]Jot Teixeira S, Martin J, McDermott Roe C, et al. CD36 and macrophages in atherosclerosis. Cardiovasc Res, 2007, 75 ( 3 ) : 468-477.
  • 2陈俊华,张向阳.CD36抗原在动脉粥样硬化发生机制中的作用[J].心血管病学进展,2008,29(5):795-798. 被引量:7
  • 3Handberg A, Skjelland M, Michelsen AE, et al. Soluble CD36 in plasma is increased in patients with symptomatic athemsclemtic carotid plaques and is related to plaque instability. Stroke, 2008, 39 ( 11 ) : 3092-3095.
  • 4Harb D, Bujold K, Febbraio M, et al. The role of the scavenger receptor CD36 in regulating mononuclear phagocyte trafficking to atherosclerotic lesions and vascular inflammation. Cardiovas Res, 2009, 83(1) : 42-51.
  • 5Park YM, Febbraio M, Silverstein RL CD36 modulates migration of mouse and human macmphages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J C lin Invest, 2009, 119(1): 136-145.
  • 6Greaves DR, Channor KM. Inflammation and immune responses in atherosclerosis. Trends Immunol, 2002, 23: 535-541.
  • 7蔡琳,刘汉雄,燕纯伯,杨源烈,刘剑雄,廖雪松,唐炯,吴镜,刘剑平,罗俊,王伟,余秀琼.胰岛素抵抗与冠状动脉狭窄严重程度的关系[J].中华心血管病杂志,2001,29(9):538-541. 被引量:36
  • 8Birrl JA. Advances in coronary angioplasty. N Engl J Med, 2006, 335 : 1290-1299.
  • 9Glagov S. Intimal hyperplasia, vascular modeling, and the restenosis problem. Circulation, 1994, 89: 2888-2991.
  • 10Welt FGP, Edelman ER, Simon DI, et al. Neutrephil, not macrophage, infiltration precedes neointimal thicking in balloon-injured arteries. Arterioscler Thromb Vasc Biol, 2000, 20: 2553-2258.

二级参考文献31

  • 1刘国仗.胰岛素抵抗及其检测方法[J].中华心血管病杂志,1996,24(1):3-4. 被引量:125
  • 2Matsumoto K, Hirano K, Nozaki S, et al. Expression of macmphage (Mphi) scavenger reeeptor,CD36 ,in cultured human aortic smooth musele ceils in association with expression of peroxisome proliferator activated receptor-gamma, which regulates gain of Mphi-like phenotypc in vitro, and its implication in atherogenesis[J]. Arterioscler Thromb Vasc Bial,2000,20 : 1027-1032.
  • 3Andersen M, Lenhard B, Whatling C, et al. Alternative promoter usage of the membrane glycoprotein CD36 [ J ]. BMC Mol Biol,2006,7:8-13.
  • 4Noushmehr H ,D' Amico E,Farilla L,et al. Fatty acid translocase (FAT/CD36) is localized on insulin containing granules in human pancreatic beta-cells and mediates fatty acid effects on insulin secretion[ J]. Diabetes,2005,54:472481.
  • 5Demers A, McNicoll N, Febbraio M, et al. Identification of the growth hormonereleasing pepfide binding site in CD36:a photo affinity cross-linking study [ J ]. Biochem J,2004,382:417-424.
  • 6Simantov R, Febbraio M, Silverstein RL. The antiangiogenic effect of thrombospondin-2 is mediated by CD36 and modulated by histidinerichglycoprotein [ J ]. Matrix Biol,2005 ,24 :27-34.
  • 7Zhang Y, Wahl LM. Synergistic enhancement of cytokine-induced human monocyte matrix metalloproteinase-1 by C-reactive protein and oxidized LDL through differential regulation of monocyte chemotactic protein-1 and prostaglandin E2 [ J]. Leukoc Biol,2006,79 : 105-113.
  • 8Podrez EA, Poliakov E, Shen Z, et al. Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36 [ J]. Biol Chem,2002 ,277 :38503-38516.
  • 9Zeng Y,Tao N, Chung KN, et al. Endocytosis of oxidized low density lipoprotein through scavenger receptor CD36 utilizes a lipid raft pathway that does not require caveolin-1 [ J]. Biol Chem,2003 ,278 :45931-45936.
  • 10Zhao M,Liu Y,Wang X ,et al. Activation of the p38 MAP kinase pathway is required for foam cell formation from macrophages exposed to oxidized LDL [ J ]. APMIS ,2002,110:458-468.

共引文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部